LMAT LEMAITRE VASCULAR, INC.
Research report · from SEC EDGAR · close 2026-07-10
$102.74 +0.3%
$2.35B mkt cap
executive summary
LEMAITRE VASCULAR, INC. (LMAT) is a $2.35B company. Revenue is $249.6M (+13.5% y/y) at a 23% net margin. It is profitable. Our health score is B (82/100). 1 red flag on file. It funds itself; low dilution risk.
Revenue (FY)
$249.6M
+13.5% y/y
⚠One-sided insider selling
4 insider sales and no open-market buys in the recent window.
who's buying
Insider buys / sells
0 / 4
Cash & ST investments
$26.9M
Operating cash flow
$81.3M
Assembled from SEC EDGAR (XBRL, Form 4, 13F, filings), STOCK Act disclosures, and end-of-day prices — every figure is real and sourced; nothing is fabricated or predicted. Filings lag 40–90 days. Educational, not investment advice. Generated 2026-07-10 by stocktools.ai.